...

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-< 2 and 2-< 12 Years Old), with Venous Thromboembolism

【24h】

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-< 2 and 2-< 12 Years Old), with Venous Thromboembolism

机译：在儿童标准抗凝血治疗后，单剂量口服Dabigatran的药代动力学，药效，安全性和耐受性（两个年龄组：1- <2和2-12岁），具有静脉血栓栓塞

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共7页
作者
Halton Jacqueline M. L.; Albisetti Manuela; Luciani Matteo; Huang Fenglei; Biss Branislav; Brueckmann Martina; Gropper Savion; Maas Hugo; Tartakovsky Igor; Mitchell Lesley G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献

1. Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-< 2 and 2-< 12 Years Old), with Venous Thromboembolism [J] . Halton Jacqueline M. L., Albisetti Manuela, Luciani Matteo, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：在儿童标准抗凝血治疗后，单剂量口服Dabigatran的药代动力学，药效，安全性和耐受性（两个年龄组：1- <2和2-12岁），具有静脉血栓栓塞
2. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28days to 6years with chronic kidney disease receiving dialysis (vol 34, pg 145, 2018) [J] . Sohn Winnie Y., Portale Anthony A., Salusky Isidro B., Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2019,第4期

机译：开放标签，单剂量研究，以评估28天至＆ 6年患有慢性肾病接受透析（Vol 34，PG 145,2018）
3. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to ?6?years with chronic kidney disease receiving dialysis [J] . Winnie Y. Sohn, Anthony A. Portale, Isidro B. Salusky, Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2019,第1期

机译：开放标签，单剂量研究，以评估28岁的儿科受试者的安全性，耐受性，药代动力学和蝶形癌的药效学和＆ 6岁，慢性肾脏疾病接受透析
4. An open-label single-dose study to evaluate the safety tolerability pharmacokinetics and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to 6 years with chronic kidney disease receiving dialysis [O] . Winnie Y. Sohn, Anthony A. Portale, Isidro B. Salusky, -1

机译：一项开放性单剂量研究评估28天至6岁的慢性肾病接受透析的小儿科西那卡塞的安全性耐受性药代动力学和药效学
5. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis [O] . Winnie Y. Sohn, Anthony A. Portale, Isidro B. Salusky, 2018

机译：开放标签，单剂量研究，以评估28天的儿科受试者的安全性，耐药性，药代动力学和蛹虫虫的药效学和慢性肾脏疾病接受透析的慢性肾脏疾病

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号